Procter & Gamble Hygiene and Health Care Limited has informed the Exchange regarding a press release dated July 30, 2025, titled "Press release for quarter ended June 30, 2025".
PGHH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
P&G Hygiene and Health Care (PGHH) reported Q1 FY26 sales of ₹937 crores, up just 1% versus the year-ago period, indicating weak top-line momentum. Profit After Tax (PAT) jumped sharply to ₹192 crores from ₹81 crores last year. The company clarified that this dramatic PAT growth is mainly because the base period (Q1 FY25) had unusually high advertising spending, which had compressed prior-year profits. The MD acknowledged a 'continually challenging operating environment' but pointed to execution of the company's integrated growth strategy across brands like Whisper, Vicks and Old Spice. The results are unaudited and were approved by the Board on July 30, 2025.
The 1% sales growth is a soft signal for shareholders, suggesting muted demand or pricing pressure in core categories. The PAT surge looks impressive on paper but is largely a statistical rebound from last year's high ad-spend base rather than genuine operational outperformance, so it should be read with caution.